Casirivimab - NDC Database
2 records found
Page:
61755-024 Nov 21, 2020
Casirivimab 1332 mg/11.1ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
Casirivimab 1332 mg/11.1ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
61755-026 Nov 21, 2020
Casirivimab 300 mg/2.5ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
Casirivimab 300 mg/2.5ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.